英格兰结肠镜检查提供者间结肠镜后结直肠癌发生率差异:基于人群的队列研究
该研究基于2005至2013年英格兰NHS数据,纳入所有接受结肠镜检查后3年内诊断为结直肠癌的人群,量化结肠镜后结直肠癌(PCCRC)发生率。NHS肠癌筛查项目下结肠镜检查的PCCRC率较低(3.6%),而由非NHS提供者进行的检查率较高(9.3%)。调整病例组合后,不同结肠镜检查提供者间的PCCRC率仍存在显著差异。
要点
- 总体PCCRC-3年率为7.4%,2005至2013年间从9.0%下降至6.5%。
- NHS肠癌筛查项目下的结肠镜检查PCCRC率较低(3.6%),非NHS提供者较高(9.3%)。
- 女性、老年、炎症性肠病或憩室病、高合并症评分及既往癌症者PCCRC率更高。
核心结论
- 英格兰NHS结肠镜检查提供者间PCCRC-3年率存在广泛差异,最低发生率见于NHS肠癌筛查项目下的结肠镜检查。
研究设计与样本
- 基于人群的队列研究,纳入2005至2013年英格兰NHS所有接受结肠镜检查后3年内诊断为结直肠癌的人群。
主要发现
- 女性、老年、炎症性肠病或憩室病、高合并症评分及既往癌症者PCCRC率更高。
- 调整病例组合后,结肠镜检查提供者间的PCCRC率仍存在显著差异。
临床怎么用
- 关注结肠镜检查质量差异,尤其非NHS提供者及高危人群(女性、老年、炎症性肠病或憩室病、高合并症、既往癌症)的PCCRC风险。
- 支持通过质量改进措施(如早期诊断、切除癌前息肉)以降低PCCRC率并改善结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To quantify post-colonoscopy colorectal cancer (PCCRC) rates in England by using recent World Endoscopy Organisation guidelines, compare incidence among colonoscopy providers, and explore associated factors that could benefit from quality improvement initiatives. DESIGN: Population based cohort study. SETTING: National Health Service in England between 2005 and 2013. POPULATION: All people undergoing colonoscopy and subsequently diagnosed as having colorectal cancer up to three years after their investigation (PCCRC-3yr). MAIN OUTCOME MEASURES: National trends in incidence of PCCRC (within 6-36 months of colonoscopy), univariable and multivariable analyses to explore factors associated with occurrence, and funnel plots to measure variation among providers. RESULTS: The overall unadjusted PCCRC-3yr rate was 7.4% (9317/126 152), which decreased from 9.0% in 2005 to 6.5% in 2013 (P<0.01). Rates were lower for colonoscopies performed under the NHS bowel cancer screening programme (593/16 640, 3.6%), while they were higher for those conducted by non-NHS providers (187/2009, 9.3%). Rates were higher in women, in older age groups, and in people with inflammatory bowel disease or diverticular disease, in those with higher comorbidity scores, and in people with previous cancers. Substantial variation in rates among colonoscopy providers remained after adjustment for case mix. CONCLUSIONS: Wide variation exists in PCCRC-3yr rates across NHS colonoscopy providers in England. The lowest incidence was seen in colonoscopies performed under the NHS bowel cancer screening programme. Quality improvement initiatives are needed to address this variation in rates and prevent colorectal cancer by enabling earlier diagnosis, removing premalignant polyps, and therefore improving outcomes.
引用
- Burr NE, Derbyshire E, Taylor J, et al. Variation in post-colonoscopy colorectal cancer across colonoscopy providers in English National Health Service: population based cohort study. BMJ. 2019. PMID: 31722875. doi:10.1136/bmj.l6090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。